Dealmaking

PE firms target clinical trial companies: 7 acquisitions

Audax Private Equity, EQT and NMS Capital are among the PE firms pursuing deals and sales in the clinical trial sector.

CVC-backed Mehiläinen buys in Lithuania; IK Partners and ECI kick off 2025 with promotions

IK Partners has opened a new office in Munich and promoted three to partner.

Carlyle’s Stephen Wise feels ‘very good about the investment environment for 2025’; why healthcare deals soared in 2024

Arcline acquires Rotating Machinery Services.

Carlyle’s Stephen Wise: 'The market is set up well for exits and financing new deals'

'2025 may bring some shifts as we welcome a new administration, potentially influencing areas like trade policies and immigration.'

Global healthcare PE deal value soared to $115bn, finds Bain & Company

The surge was propelled by an increase in large deals and greater interest in biopharma and healthcare IT, Nirad Jain said in an exclusive interview with PE Hub.

Epiris has strong deal pipeline for 2025; Ardian closes first PE continuation fund

The vehicle is Ardian’s first private equity continuation fund, and it will be managed by Ardian, capitalized by Eurazeo as senior lead investor and Astorg as co-lead investor.

Epiris' Owen Wilson wishes for 'focused transparency' in 2025

Epiris' deals in 2024 include the acquisition of Amber Taverns, which operates pubs predominantly in north England.

Emerging venture markets see sharp investment decline

VCs invested a total of $9.1bn in emerging venture markets in 2024, down from $15.3bn in 2023 and a high of $25.1bn in 2021.

Churchill remains bullish on junior capital; Genstar eyes M&A and organic growth for Aperture

Genstar is acquiring forensic experts provider Aperture.

Churchill's Anne Philpott: 'Investors will flock to junior capital to lock in long-term, fixed rate return stability'

'Junior capital offers delayed draw capacity, which is a critical source of funding for sponsors with buy-and-build investment strategies seeking to make post-closing acquisitions.'